PCV4 Thromboprophylaxis and the Risk of Post-Discharge Venous Thromboembolism and Bleeding in Patients Undergoing Total Hip or Knee Arthroplasty

M. H. Huo(The University of Texas Southwestern Medical Center), Winslow Klaskala(Johnson & Johnson (United States)), Yueguang Fan(Optum (United States)), Roger M. Mills(Janssen (Belgium)), Bijan J. Borah(Mayo Clinic in Florida), Donna Spencer(Optum (United States))
Value in Health
May 23, 2012
Cited by 0


Related Papers